L’élimination du paludisme nécessite l’engagement de tous. Afin de maintenir les communautés alertes et engagées, nous allons nous appuyer sur des exemples réussis d’engagement communautaire pour élaborer un programme de sensibilisation sur le paludisme en milieu communautaire et ce par ...des acteurs issus de la communauté ayant au préalable bénéficié d’une formation par des techniciens de la santé.
Ce programme qui a pour ambition d’être multisectoriel, vient renforcer les initiatives déjà mises en œuvre au sein de la communauté. A l’opposé des dispensateurs de soins à domicile (DSDOM) ou acteurs communautaires de soins, les champions communautaires sur lesquels se basera le programme en question n’auront pour objectif que la sensibilisation par la communication pour le changement de comportement. En soutien aux activités mises en œuvre par les districts et leurs partenaires, le programme vise à renforcer les capacités et l’encadrement de personnes bénévoles qui souhaitent s’impliquer ou sont déjà impliquées pour l’amélioration du cadre de vie et la santé de leur communauté et ainsi contribuer à l’élimination du paludisme au Sénégal.
Enfin, ce guide vient en complément au guide de formation sur le paludisme pour le relais communautaire, développé par le Programme National de Lutte contre le Paludisme (PNLP) en octobre 2015.
more
Participant Manual September 2012
Surveillance of Populations at High Risk for HIV Transmission
Participant Manual
February 2011
Edition 3.0
Participant Manual September 2009
Participant Manual
October 2009
Global temperatures and the frequency and intensity of heatwaves will rise in the 21st century as a result of climate change. Extended periods of high day and nighttime temperatures create cumulative physiological stress on the human body which exacerbates the top causes of death globally, including... respiratory and cardiovascular diseases, diabetes mellitus and renal disease. Heatwaves can acutely impact large populations for short periods of time, often trigger public health emergencies, and result in excess mortality, and cascading socioeconomic impacts
more
This document puts forward the joint position and vision of an expert, global, multistakeholder working group on implementing Kangaroo Mother Care (KMC) for all preterm or low birth weight (LBW) infants as the foundation for small and/or sick newborn care within maternal, newborn, and child health p...rogrammes, and spur collaborative global action. The document summarizes the background information, evidence, and rationale for making KMC available to every preterm or LBW newborn and seeks to galvanize the international maternal, newborn, and child health community and families to come together to support the implementation of KMC for all preterm or LBW infants to improve their and their mothers and families health and well-being.
This position paper is intended to be used by policy-makers (i.e. those responsible for national policy, guideline development and budget allocation), development partners, programme managers, health workforce leadership, practising clinicians, civil society leadership (e.g. parent and professional organizations) and researchers/research organizations involved in KMC implementation research.
more
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...erms of actual versus expected national domestic funding, considering resource needs and donor financing. With UNAIDS and World Bank data, we examine domestic and donor HIV program funding in relation to need in 84 low- and middle-income countries. We estimate expected domestic contributions per person living with HIV (PLWH) as a function of per capita income, relative size of the health sector, and per capita foreign debt service.
more
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...ich operates within the WHO coordinated Global Yellow Fever Laboratory Network (GYFLaN) capable of providing confirmation of yellow fever infection reliably and timely. This second edition supersedes the first edition of the 2004 WHO manual for the monitoring of yellow fever virus infection.
more
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...t of diphtheria. There is a worldwide shortage of DAT and evidence based recommendations on the use of DAT were requested by many Member States.
The guidance also includes new recommendations on antibiotics. In patients with suspected or confirmed diphtheria, WHO recommends using macrolide antibiotics (azithromycin, erythromycin) rather than penicillin antibiotics.
This clinical practice guideline has been rapidly developed recognizing the global increase in diphtheria outbreaks. Outbreaks of diphtheria in Nigeria, Guinea and neighbouring countries in 2023 have highlighted the urgent need for evidence-based clinical practice guidelines for the treatment of diphtheria. Given the sporadic nature of outbreaks, many clinicians in the affected regions have never managed acute diphtheria and its related complications. Diphtheria remains a neglected disease and vaccination is the top priority. At the same time, for patients with diphtheria, access to antibiotics, DAT and supportive care can be lifesaving.
more